A supplier of plastic packaging and contract manufacturing services to medical device OEMs, Comar has announced a major capacity expansion of its Buena, NJ, plant operations by building a new offsite location in nearby Vineland, NJ. The new 159,000 square-foot facility will house injection molding and assembly and finishing machines, with additional capacity to support long-term growth. It will be ISO 13485 certified, cGMP compliant, and FDA registered, added Comar. The expansion is scheduled for completion by March 2021.
The Buena expansion effort will result in a range of benefits, said Comar, including the following:
- Increased space for injection molding, assembly and finishing operations;
- increased warehouse and storage space;
- improved facility layout with more dedicated product cells to drive speed to market;
- improved cGMP environment and quality lab; and
- improved design to enable better efficiency, safety, and employee experience.
“This investment builds on our new West Coast facility — Rancho 2.0 — and represents another exciting milestone for our organization,” said Mike Ruggieri, CEO. Comar announced in February of this year the construction of a custom manufacturing facility in Rancho Cucamonga, CA. At the time, it said that production would begin by the end of 2020. The facility will support manufacturing of complex finished medical devices and sub-assemblies, incorporating injection molding, blow molding, high-speed assembly, testing, and finished device pack-out.
Noting that Comar’s Buena plant has been an engine of growth over the decades, Ruggieri added that the “next critical step of adding footprint, infrastructure, and capacity will ensure that we continue to delight our customers and drive our growth moving forward.”
Image: IQ Concept/Adobe Stock